Leading NCI-Designated Cancer Centers Across the Country Leverage ConcertAI’s CancerLinQ to Support Personalized, Evidence-Based Quality Care

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI®, the real‑world healthcare intelligence company for those advancing research, treatment, and care in oncology and other complex diseases, today announced that University of Rochester Medicine Wilmot Cancer Institute and UCHealth/University of Colorado Anschutz Cancer Center have joined its CancerLinQ® network, helping close care gaps and elevate oncology outcomes. These additions increase the platform’s ability to generate real-world evidence across
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks